MTACU MedTech Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)

MedTech Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses primarily operating in the healthcare sector in the United States. The company was founded in 2020 and is based in New York, New York.  This security was issued by MedTech Acquisition Corporation Class A, whose common stock symbol is MTAC.

On 8/19/2021 the company announced a pending merger with Memic Innovative Surgery Ltd., an Israeli based medical device company, founded and grown in Peregrine's incubator, that has developed the Hominis, a robotic platform for surgical procedures.  

$10.27
As of 10/27/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Units
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  12/17/2020
Outstanding shares:  20,000,000
Average volume:  9,720
Market cap:   $247,500,000
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy